Display options
Share it on

Iran J Public Health. 2018 Sep;47(9):1272-1280.

The Association between .

Iranian journal of public health

Zeng Zhuanping, Liao Rifang, Chen Qing, Chen Sidong

Affiliations

  1. School of Public Health, Guangdong Pharmaceutical University, Guangzhou 510310, China.
  2. Dept. of Pharmacy, Sun Yat-Sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
  3. Dept. of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou 510515, China.

PMID: 30320001 PMCID: PMC6174046

Abstract

BACKGROUND: To examine whether polymorphisms of

METHODS: In this community-based, case-control study, 568 subjects (284 patients and 284 controls) were enrolled in a community located in northern Guangzhou, China. The four polymorphisms of

RESULTS: The rs4746720 CC+TT genotype had higher risk compared with CT genotype to develop T2DM [odds ratio (OR) =1.42, 95% confidence interval (CI) = 1.02-1.97]. The subjects with rs4746720 CC+TT genotype and eat sugar food over 30g per day increased the risk of T2DM to 2.22(1.21-4.06) times. The subjects with rs4746720 CC+TT genotype and smoking increased the risk of T2DM to 1.65 (1.10-2.47) times. The unhealthy eating habits such as red meat, salty food, use animal fat yielded higher risks of T2DM, the OR of risk of T2DM was 2.89 (1.38-6.01), 2.73 (1.61-4.64) and 27.91(9.24-84.32) respectively. However, the milk, soy, white meat, vegetables and low-salt diet decreased the risk of T2DM, the OR of risk of T2DM was 0.51 (0.29-0.88), 0.43 (0.26-0.74), 0.51(0.32-0.83), 0.21(0.10-0.44), 0.28(0.12-0.65), 0.35(0.21-0.51) respectively.

CONCLUSION: Variants in

Keywords: China; Dietary; Sirtuin 1; Type 2 diabetes mellitus

Conflict of interest statement

Conflict of interest The authors declare that there is no conflict of interests.

References

  1. JAMA. 2011 Mar 2;305(9):903-12 - PubMed
  2. Scand J Clin Lab Invest. 1960;12(4):402-7 - PubMed
  3. Gene. 2015 Jun 1;563(2):150-4 - PubMed
  4. Endocr Metab Immune Disord Drug Targets. 2010 Mar;10(1):16-24 - PubMed
  5. J Clin Endocrinol Metab. 2015 Aug;100(8):3112-7 - PubMed
  6. Clin Chim Acta. 2010 Nov 11;411(21-22):1679-83 - PubMed
  7. BMC Vet Res. 2013 Sep 27;9:187 - PubMed
  8. Cell Metab. 2012 May 2;15(5):675-90 - PubMed
  9. Endocr J. 2012;59(3):229-37 - PubMed
  10. J Diabetes Investig. 2016 Nov;7(6):845-852 - PubMed
  11. Am J Epidemiol. 2005 Feb 1;161(3):219-27 - PubMed
  12. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253 - PubMed
  13. Yonsei Med J. 2013 Mar 1;54(2):352-7 - PubMed
  14. Arch Intern Med. 2007 May 14;167(9):956-65 - PubMed
  15. J Biol Chem. 2005 Mar 18;280(11):9780-5 - PubMed
  16. Int J Epidemiol. 2010 Jun;39(3):889-99 - PubMed
  17. J Lipid Res. 2013 Feb;54(2):467-72 - PubMed
  18. J Manag Care Spec Pharm. 2017 Apr;23(4):446-452 - PubMed
  19. Diabetes. 2013 Jan;62(1):291-8 - PubMed
  20. J Nutr Sci. 2016 Aug 16;5:e34 - PubMed
  21. Free Radic Biol Med. 2009 Mar 15;46(6):836-41 - PubMed
  22. Diabetes Care. 2004 Jan;27(1):134-40 - PubMed
  23. Int J Obes (Lond). 2006 Apr;30(4):669-76 - PubMed
  24. Nutr Res Rev. 2016 Dec;29(2):249-267 - PubMed
  25. Mol Genet Metab. 2011 Dec;104(4):661-5 - PubMed
  26. Diabetes Metab J. 2013 Oct;37(5):315-25 - PubMed

Publication Types